1. Kano Y, Shiohara T. The variable clinical picture of 
drug‑induced hypersensitivity syndrome/drug rash with 
eosinophilia and systemic symptoms in relation to the eliciting 
drug. Immunol Allergy Clin North Am 2009;29:481‑501.
2. Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report 
of a case of hepatitis with jaundice, pyrexia and exfoliative 
dermatitis. N Engl J Med 1950;242:897‑8.
3. Tetsuo Shiohara, Yoko Kano, Ryo, Takahashi. Current 
Concepts on the Diagnosis and pathogenesis of Drug‑induced 
Hypersensitivity Syndrome . JMAJ 2009;52:347-52.
4. Akcam FZ, Aygun FO, Akkaya VB. DRESS like severe drug 
rash with eosinophilia, atypic lymphocytosis and fever 
secondary to ceftriaxone. J Infect 2006;53:e51‑3.
5. Kardaun SH, Sidoroff A, Valeyrie‑Allanore L, Halevy S, 
Davidovici BB, Mockenhaupt M, et al. Variability in the clinical 
pattern of cutaneous side‑effects of drugs with systemic 
symptoms: Does a DRESS syndrome really exist? Br J Dermatol 
s2007;156:609‑11.
6. Choquet‑Kastylevsky G, Intrator L, Chenal C, Bocquet H, 
Revuz J, Roujeau JC. Increased levels of interleukin 5 are 
associated with the generation of eosinophilia in drug‑induced 
hypersensitivity syndrome. Br J Dermatol 1998;139:1026‑32.
7. Bocquet H, Bagot M, Roujeau JC. Drug‑induced 
pseudolymphoma and drug hypersensitivity syndrome (Drug 
Rash with Eosinophilia and Systemic Symptoms: DRESS). 
Semin Cutan Med Surg 1996;15:250‑7.
8. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The 
diagnosis of a DRESS syndrome has been sufficiently 
established on the basis of typical clinical features and viral 
reactivations. Br J Dermatol 2007;156:1083‑4.
9. ZulianiE, ZwahlenH, GillietF, MaroneC. Vancomycin‑induced 
hypersensitivity reaction with acute renal failure: Resolution 
following cyclosporine treatment. Clin Nephrol 2005;64:155‑8.